Indian-origin healthcare professionals continue to play a measurable role in shaping global medicine across clinical practice, public health policy, pharmaceutical innovation, and health communication. Their contributions span multiple geographies, particularly in the United States and the United Kingdom, where they form a significant part of the healthcare workforce and leadership ecosystem.
According to the Organisation for Economic Co-operation and Development (OECD), India is the largest source of migrant doctors globally and the second-largest source of nurses, highlighting the systemic reliance on Indian-origin professionals in advanced healthcare systems.
This article examines a group of moderately prominent Indian-origin healthcare leaders whose work intersects with global health governance, research, and delivery systems.
Indian-origin physicians represent a substantial proportion of the medical workforce in developed nations. In the United States alone, over 59,000 Indian-origin doctors account for approximately 22% of immigrant physicians, contributing significantly to both urban and underserved healthcare settings.
Their roles extend beyond clinical care into:
Public health policy
Medical education
Healthcare communication
Pharmaceutical leadership
These contributions align with broader trends where Indian-origin professionals increasingly occupy leadership positions in major global institutions.
Sworn in as the 180th president of the American Medical Association (AMA) in June 2025, Dr. Mukkamala became the first physician of Indian heritage to lead the organization. His role places him at the center of U.S. healthcare policy discussions, including physician workforce challenges and healthcare access. He was born in Michigan to Indian immigrant doctors from Andhra Pradesh.
As former White House COVID-19 Response Coordinator in 2022-23 and current Dean of the Brown University School of Public Health, Dr. Jha contributed to pandemic response frameworks, particularly in translating epidemiological data into public-facing guidance.
A surgeon, researcher, and academic, Dr. Gawande has contributed to global discussions on patient safety and healthcare system design. He was assistant administrator of the United States Agency for International development for Global health. Currently a professor at Harvard medical school. His work emphasizes surgical outcomes, checklist-based safety protocols, and scalable health delivery models.
A gastroenterologist, Dr. Sharma serves as the president of the American Society for Gastrointestinal Endoscopy. He is a professor of medicine at the University of Kansas school of medicine. Dr. Sharma’s work focuses on advancing endoscopic techniques and improving early detection of gastrointestinal diseases.
Recognized in 2026 with the Hind Rattan Award, he is a renowned hematologist and oncologist based in South Carolina. Dr. Patel has contributed to community oncology in the United States, particularly advocating for equitable cancer care in underserved populations. He is the CEO of the Carolina blood and cancer care associates.
As CEO of Vertex Pharmaceuticals, Dr. Kewalramani was the first female CEO of a large US biotech company and has overseen the development and approval of therapies targeting complex diseases, including cystic fibrosis. Her leadership reflects the growing presence of Indian-origin professionals in global biotech innovation.
CEO of Novartis since 2018, Dr. Narasimhan has focused on drug development pipelines, digital transformation, and expanding access to advanced therapeutics.
Pharmaceutical innovation remains a key pillar of global health, with multinational organizations contributing to drug development, clinical trials, and digital health integration.
A Malayali nurse elected to the Royal College of Nursing (UK), Sebastian represents the growing influence of Indian-origin professionals in nursing leadership. Indian nurses form a critical component of healthcare delivery systems globally, complementing physician-led care.
The impact of Indian-origin professionals is supported by India’s broader healthcare ecosystem:
India supplies approximately 60% of global vaccines and exports to over 170 countries
The country is a major hub for clinical research and biomedical studies
Indian professionals contribute to transnational research collaborations and public health initiatives
Additionally, Indian-origin professionals often bridge healthcare systems across countries, facilitating knowledge exchange and capacity building.
Indian-origin healthcare professionals occupy a range of roles across global medicine, including clinical practice, policy-making, research, communication, and industry leadership. Their presence reflects both the scale of India’s medical workforce and the increasing globalization of healthcare systems.
As healthcare challenges become more interconnected—spanning pandemics, chronic diseases, and health equity—these professionals continue to contribute within institutional, academic, and clinical frameworks worldwide.
(TL)